Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Caulfield confirmed as new pharmacy minister

Lewes MP Maria Caulfield has been appointed as minister in charge of the pharmacy portfolio following a cabinet reshuffle.

Her appointment came just days after Maggie Throup, MP for Erewash, was appointed parliamentary under secretary of state for Prevention, Public Health and Primary Care on September 16 following a cabinet reshuffle by prime minister Boris Johnson.


At the time it appeared like a 'like for like' replacement for Jo Churchill who was moved to Defra.

The Department of Health and Social Care told Pharmacy Business on Friday (September 24) that the ministerial responsibilities "were still being finalised" after the previous week's cabinet reshuffle and confirmed that Maria Caufield has taken over from Jo Churchill as the minister responsible for pharmacy.

A three MP, Caulfield entered parliament in 2015 after her election victory from the East Sussex constituency on a Conservative Party ticket. She won her subsequent elections form the same constituency in 2017 and 2019.

Caulfield was appointed vice chair for women of the Conservative Party in 2018 and was named an assistant government whip, focusing on the work of the Departments for Culture and International Trade, while also looking after the welfare of a group of MPs.

A nurse by profession, Caulfield was born in 1973 to Irish immigrant parents living in Wandsworth, London, where she grew up. She lives with her husband, an ex-serviceman and former builder, who now works as her office manager.

More For You

Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less
Wales ranked worst for second-trimester abortion access in the UK

Each year about 175 women travel from Wales to England for care

Wales ranked worst for second-trimester abortion access in the UK

A leading healthcare charity has revealed that Wales is the worst part of the United Kingdom for allowing surgical abortions for women.

Surgical abortion is the process removing pregnancy from the womb by inducing local anaesthesia, conscious sedation or general anaesthesia.

Keep ReadingShow less
The fund offers £150 per eligible child - for up to three children per household.

The fund offers £150 per eligible child - for up to three children per household.

Charity reopens funding to ease back to school financial pressures for community pharmacists

Community pharmacists struggling with the costs of their children going back to school can apply for funding from The Leverhulme Trade Charities Trust (LTCT)

The Trust is providing up to £100,000 of support to those working in a community pharmacy or are a registered pharmacist or pharmacy technician

Keep ReadingShow less
Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less
Amandeep Doll RPS  New Director of England

Amandeep Doll

RPS announces new director of England

Amandeep Doll has been named as the new director for England at the Royal Pharmaceutical Society (RPS).

The role of Director for England drives professional leadership for the pharmacy profession in England, and leads on national policy development and advocacy across England, in partnership with the English Pharmacy Board.

Keep ReadingShow less